Back to 
BAKER BROS. ADVISORS LP
BAKER BROS. ADVISORS LP
SNSE1 quarters
Position history for BAKER BROS. ADVISORS LP's holdings in FAETH THERAPEUTICS INC
Yes. Baker Bros. Advisors holds 1,286,411 shares of SNSE (Faeth Therapeutics), worth $32.2M, as of its Q2 2026 13F filing. It opened the position in Q2 2026. SNSE is 0.2% of Baker Bros. Advisors' reported 13F portfolio.
Current Value
$32.2M
Current Shares
1.3M
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of SNSE: Avoro Capital Advisors LLC, BALYASNY ASSET MANAGEMENT L.P., RA CAPITAL MANAGEMENT, L.P., FRANKLIN TEMPLETON INC, MARSHALL WACE, LLP